Multivalent nanosystems: targeting monocytes/macrophages

Rémy Poupot1, Cécile Goursat1, Séverine Fruchon1

  • 1INSERM, U1043, CNRS, U5282, Université de Toulouse, UPS; Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France, severine.fruchon@inserm.fr.

Insights

Monocytes and macrophages regulate inflammation and are key therapeutic targets. Engineered nanosystems can target these cells to treat inflammatory diseases.

Area of Science:

  • Immunology
  • Nanotechnology
  • Pharmacology

Background:

  • Monocytes and macrophages are central regulators of inflammatory processes across virtually all tissues.
  • Their critical role makes them significant therapeutic targets for inflammatory disorders.
  • Macrophages possess inherent phagocytic capabilities, interacting with nanoparticles.

Purpose of the Study:

  • To review recent advancements in multivalent nanosystems designed for targeting monocytes and macrophages.
  • To explore the potential of engineered nanosystems in modulating or eliminating detrimental macrophages in vivo.
  • To highlight strategies for developing multifunctional nanosystems for inflammatory disease treatment.

Main Methods:

  • Literature review of recent articles and concepts.
  • Analysis of engineered nanosystems targeting monocytes and macrophages.
  • Focus on multivalent and multifunctional nanoparticle design.

Main Results:

  • Nanosystems can be rationally engineered for multivalent and multifunctional properties.
  • Targeted nanosystems can be loaded with drugs to modulate macrophage activity.
  • Engineered entities show promise for eradicating deleterious macrophages in vivo.

Conclusions:

  • Multivalent nanosystems offer a promising strategy for targeting monocytes and macrophages.
  • Engineered nanoparticles can be utilized to modulate macrophage-driven inflammation.
  • These targeted nanosystems represent a novel therapeutic avenue for inflammatory disorders.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Affinity and Avidity01:41

Affinity and Avidity

Overview
39.1K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.0K
Inflammation01:38

Inflammation

Overview
62.1K